Viewing StudyNCT00082381



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00082381
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2004-05-06

Brief Title: Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: H8O-MC-GWAA
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Eli Lilly and Company INDUSTRY